User login
Artificial intelligence (AI) applications are expanding rapidly in healthcare. AI powered tools are increasingly used in everyday medical practice, assisting clinicians with tasks such as diagnosis, treatment planning, data analysis, and patient monitoring, effectively integrating AI into routine clinical decision making. Despite its potential to fundamentally transform the practice of medicine and healthcare delivery, AI in healthcare remains largely unregulated, with a lack of common standards to guide responsible design, development, and adoption of AI-based tools to guide clinical care.
But this is changing. In mid-January, the US Department of Health & Human Services released its Strategic Plan for the Use of AI in Health, Human Services, and Public Health (available at www.healthit.gov), presenting an approach to catalyze innovation, promote trustworthy AI development, democratize technologies and resources, and cultivate AI-empowered workforces and organizational cultures. While there is no immediate regulatory impact, the plan does provide important insights into how the federal government thinks about AI, which will be a part of driving regulations in the future. As crucial stakeholders in the health AI universe and advocates for its responsible use in clinical practice, it is critical that we as clinicians keep abreast of developments in this rapidly evolving space.
In this month’s issue of GI & Hepatology News, we summarize a recent systematic review and meta-analysis highlighting worsening health disparities for Hispanic adults with MASLD. We also report the results of an industry-sponsored study comparing the real-world clinical effectiveness of GI Genius (an AI-driven tool) with that of standard colonoscopy.
In February’s Member Spotlight, we introduce you to international AGA member Dr. Tossapol Kerdsirichairat (clinical associate professor of gastroenterology at Bumrungrad International Hospital in Bangkok, Thailand), who shares his insights regarding the challenges and rewards of practicing gastroenterology at one of the largest private hospitals in Southeast Asia. ‘Tos’ is one of roughly 25% of AGA members who live and work outside the United States.
Finally, this month’s In Focus column from The New Gastroenterologist focuses on management of chronic constipation, a highly prevalent condition that significantly impacts the quality of life of many of our patients. We hope you enjoy this and all the exciting content in our February issue.
Megan A. Adams, MD, JD, MSc
Editor in Chief
Artificial intelligence (AI) applications are expanding rapidly in healthcare. AI powered tools are increasingly used in everyday medical practice, assisting clinicians with tasks such as diagnosis, treatment planning, data analysis, and patient monitoring, effectively integrating AI into routine clinical decision making. Despite its potential to fundamentally transform the practice of medicine and healthcare delivery, AI in healthcare remains largely unregulated, with a lack of common standards to guide responsible design, development, and adoption of AI-based tools to guide clinical care.
But this is changing. In mid-January, the US Department of Health & Human Services released its Strategic Plan for the Use of AI in Health, Human Services, and Public Health (available at www.healthit.gov), presenting an approach to catalyze innovation, promote trustworthy AI development, democratize technologies and resources, and cultivate AI-empowered workforces and organizational cultures. While there is no immediate regulatory impact, the plan does provide important insights into how the federal government thinks about AI, which will be a part of driving regulations in the future. As crucial stakeholders in the health AI universe and advocates for its responsible use in clinical practice, it is critical that we as clinicians keep abreast of developments in this rapidly evolving space.
In this month’s issue of GI & Hepatology News, we summarize a recent systematic review and meta-analysis highlighting worsening health disparities for Hispanic adults with MASLD. We also report the results of an industry-sponsored study comparing the real-world clinical effectiveness of GI Genius (an AI-driven tool) with that of standard colonoscopy.
In February’s Member Spotlight, we introduce you to international AGA member Dr. Tossapol Kerdsirichairat (clinical associate professor of gastroenterology at Bumrungrad International Hospital in Bangkok, Thailand), who shares his insights regarding the challenges and rewards of practicing gastroenterology at one of the largest private hospitals in Southeast Asia. ‘Tos’ is one of roughly 25% of AGA members who live and work outside the United States.
Finally, this month’s In Focus column from The New Gastroenterologist focuses on management of chronic constipation, a highly prevalent condition that significantly impacts the quality of life of many of our patients. We hope you enjoy this and all the exciting content in our February issue.
Megan A. Adams, MD, JD, MSc
Editor in Chief
Artificial intelligence (AI) applications are expanding rapidly in healthcare. AI powered tools are increasingly used in everyday medical practice, assisting clinicians with tasks such as diagnosis, treatment planning, data analysis, and patient monitoring, effectively integrating AI into routine clinical decision making. Despite its potential to fundamentally transform the practice of medicine and healthcare delivery, AI in healthcare remains largely unregulated, with a lack of common standards to guide responsible design, development, and adoption of AI-based tools to guide clinical care.
But this is changing. In mid-January, the US Department of Health & Human Services released its Strategic Plan for the Use of AI in Health, Human Services, and Public Health (available at www.healthit.gov), presenting an approach to catalyze innovation, promote trustworthy AI development, democratize technologies and resources, and cultivate AI-empowered workforces and organizational cultures. While there is no immediate regulatory impact, the plan does provide important insights into how the federal government thinks about AI, which will be a part of driving regulations in the future. As crucial stakeholders in the health AI universe and advocates for its responsible use in clinical practice, it is critical that we as clinicians keep abreast of developments in this rapidly evolving space.
In this month’s issue of GI & Hepatology News, we summarize a recent systematic review and meta-analysis highlighting worsening health disparities for Hispanic adults with MASLD. We also report the results of an industry-sponsored study comparing the real-world clinical effectiveness of GI Genius (an AI-driven tool) with that of standard colonoscopy.
In February’s Member Spotlight, we introduce you to international AGA member Dr. Tossapol Kerdsirichairat (clinical associate professor of gastroenterology at Bumrungrad International Hospital in Bangkok, Thailand), who shares his insights regarding the challenges and rewards of practicing gastroenterology at one of the largest private hospitals in Southeast Asia. ‘Tos’ is one of roughly 25% of AGA members who live and work outside the United States.
Finally, this month’s In Focus column from The New Gastroenterologist focuses on management of chronic constipation, a highly prevalent condition that significantly impacts the quality of life of many of our patients. We hope you enjoy this and all the exciting content in our February issue.
Megan A. Adams, MD, JD, MSc
Editor in Chief